|
Real-time Estimate
Cboe Europe
17:01:15 13/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 123.81 CHF | -0.31% |
|
-0.99% | +13.08% |
| 04:08pm | Drugmakers curb Swiss reimbursement applications over US pricing concerns | RE |
| 08-12 | PeptiDream Hits Milestone as Novartis Begins Phase 1 Trial for Cancer Therapy | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- NOVN Stock
- Consensus Novartis AG
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
